Inventor profile of:

Alexander Levitzki

City:

Jerusalem

Country:

Israel

Published Applications:

30

Last publication date:

2024-02-01

Recent patent applications by Levitzki Alexander

Alexander Levitzki from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-01
US20240033364A1
Human necessities

CASTRATION RESISTANT PROSTATE CANCER

#2 | 2022-07-07
US20220213158A1
Chemistry; metallurgy

CHIMERIC PROTEINS FOR TARGETING dsRNA

#3 | 2022-06-09
US20220175814A1
Human necessities

IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

#4 | 2020-12-31
US20200407453A1
Chemistry; metallurgy

A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN

#5 | 2020-07-23
US20200230248A1
Human necessities

Castration resistant prostate cancer

#6 | 2019-06-27
US20190194282A1
Chemistry; metallurgy

Chimeric proteins for targeting dsRNA

#7 | 2018-12-06
US20180346596A1
Chemistry; metallurgy

Chimeric proteins for targeting dsRNA

#8 | 2018-03-08
US20180064725A1
Human necessities

IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases

#9 | 2016-06-09
US20160158243A1
Human necessities

IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases

#10 | 2014-11-06
US20140329901A1
Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#11 | 2013-10-17
US20130274251A1
Chemistry; metallurgy

2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of cancer

#12 | 2013-05-02
US20130109706A1
Chemistry; metallurgy

Quinazoline-based T cell proliferation inhibitors

#13 | 2012-08-23
US20120214850A1
Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#14 | 2012-04-05
US20120083528A1
Human necessities

NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF

#15 | 2012-01-26
US20120021006A1
Chemistry; metallurgy

EGFR-homing double-stranded RNA vector for systemic cancer treatment

#16 | 2011-07-21
US20110177102A1
Human necessities

Targeted double stranded RNA mediated cell killing

#17 | 2011-05-05
US20110105618A1
Chemistry; metallurgy

Modulators of protein kinase signaling

#18 | 2011-01-27
US20110021805A1
Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#19 | 2010-03-04
US20100056635A1
Chemistry; metallurgy

Protein kinase modulators and therapeutic uses thereof

#20 | 2009-06-18
US20090156507A1
Human necessities

Cell permeable conjugates of peptides for inhibition of protein kinases

#21 | 2008-03-06
US20080056990A1
Chemistry; metallurgy

Polyalkylene glycol derivatives of inhibitors of epidermal growth factor receptor tyrosine kinase

#22 | 2007-05-15
US10602617
-

Method and compositions for inhibiting cell proliferative disorders

#23 | 2007-04-05
US20070078092A1
Human necessities

Cell permeable conjugates of peptides for inhibition of protein kinases

#24 | 2007-02-15
US20070036764A1
Chemistry; metallurgy

Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR

#25 | 2007-02-06
US10659747
-

Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy

#26 | 2007-01-11
US20070010467A1
Human necessities

Targeted double stranded RNA mediated cell killing

#27 | 2006-02-02
US20060025430A1
Chemistry; metallurgy

Novel irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and uses thereof for therapy and diagnosis

#28 | 2005-12-15
US20050277680A1
Chemistry; metallurgy

Compounds for treatment of cell proliferative diseases

#29 | 2005-09-27
US10296624
-

Protein kinase inhibitors

#30 | 2005-06-30
US20050143430A1
Chemistry; metallurgy

Catechol bioisosteres

InventorID:

224309 ⎘